Bouchet A, Muller B, Olagne J, Barba T, et al. Evolution of humoral lesions on follow-up biopsy stratifies the risk for renal graft loss after antibody-mediated rejection treatment. Nephrol Dial Transplant 2022;37:2555-2568.
PMID: 35675302